SOLICITATION NOTICE
66 -- Multi-Mode Micro-Plate Detection Platform
- Notice Date
- 3/21/2017
- Notice Type
- Presolicitation
- NAICS
- 334510
— Electromedical and Electrotherapeutic Apparatus Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02RC73802-53
- Archive Date
- 4/20/2017
- Point of Contact
- Terry Galloway, Phone: 301-846-6654, Roman Davydov, Phone: 301-846-7648
- E-Mail Address
-
gallowaytl@mail.nih.gov, roman.davydov@nih.gov
(gallowaytl@mail.nih.gov, roman.davydov@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E638, Bethesda, MD 20892, UNITED STATES Description National Cancer Institute (NCI), Center for Cancer Research (CCR), plans to procure on a sole source basis a SpectraMax iD3 Multi-Mode Microplate Platform (including: reader, pc, notebook bundle) from Molecular Devices LLC. at 1311 Orleans Drive, Sunnyvale, CA 94089. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR 13.106-1(b)(1) and FAR 13.501-(a)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 334510 and the business size standard is 1,250 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Delivery will be within 30 days of receipt of purchase order. It has been determined there are no opportunities to acquire green products or services for this procurement. Department Background The Women's Malignancies Branch (WMB) of CCR, NCI is fully engaged in developing targeted therapeutics for all types of cancer affecting women. Ovarian, Cervical and Breast cancer affect hundreds of thousands of women each year. Therefore, it is clearly of benefit to all section of the WMB, the NCI and the NIH, and hence to the government, to facilitate studies that will enable discovery of treatment and prevention of these types of cancer. The purchase and operation of a multi-mode microplate platform will advance the governmental mission of the Women's Malignancies Branch to promote the health and well-being of all women. Purpose of Purchase The current focus of the WMB laboratory is set up for the development of more effective therapy by identifying molecular pathways that are critical to the growth and survival of cancer cells and on targeting these pathways as treatment. The laboratory studies are aimed at a better understanding of signal transduction pathways that regulate growth and programmed cell death in epithelial cancer cells in order to develop more effective therapies. There are currently two projects in need of the required equipment. The first is a basic project that investigates the regulation of receptor tyrosine kinase (RTK) function by Cbl proteins in epithelial cells. The second is a translational project that investigates the manipulation of signal transduction and apoptosis pathways as a means to kill breast cancer cells. Salient characteristics The reader must have the ability to read UV/VIS Absorbance, top/bottom read Fluorescence and Luminescence in microplate (6-384 well) format and uses monochromators for all the above including fluorescence; no filters are required which increase the reliability of the data while decreasing the background effects. The plate-reader must measure absorbance, fluorescence, and luminescence with a single lamp. In addition, the reader also must have a touch screen that can connect to the NCI network so that each user can simply send their data results to their own desktop without any need for transfer to a server or a flash drive. This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 3:00 PM EST, on April 05, 2017. All responses and questions must be in writing and emailed to Roman Davydov, Contract Specialist, via electronic mail at roman.davydov@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration and the Online Representations and Certifications Applications through the System for Awards Management website (sam.gov). Reference: N02RC73802-53 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02RC73802-53/listing.html)
- Record
- SN04441931-W 20170323/170321234550-370ed35b98ea2a9cda1f3886bd14b2e7 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |